Relmada Therapeutics
RLMD
RLMD
75 hedge funds and large institutions have $469M invested in Relmada Therapeutics in 2020 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
47% more capital invested
Capital invested by funds: $319M → $469M (+$150M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
6.49% more ownership
Funds ownership: 62.63% → 69.12% (+6.5%)
Holders
75
Holding in Top 10
4
Calls
$11.2M
Puts
$513K
Top Buyers
| 1 | +$33.1M | |
| 2 | +$22.2M | |
| 3 | +$12.4M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$12.3M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$8.95M |
Top Sellers
| 1 | -$35.8M | |
| 2 | -$23.6M | |
| 3 | -$10.9M | |
| 4 |
VA
VR Adviser
New York
|
-$7.8M |
| 5 |
Goldman Sachs
New York
|
-$3.62M |